The main cause of upper gastrointestinal bleeding due to cirrhosis is usually bleeding from ruptured esophageal varices caused by portal hypertension. At present, the commonly used clinical methods to stop bleeding are mainly pharmacological treatment (among which growth inhibitors are the most effective), three-lumen diathermy tube compression, and endoscopic hemostasis, but none of these methods can fundamentally solve the ruptured esophageal variceal bleeding in patients with cirrhosis, and the risk of rebleeding is still high. Transjugular intrahepatic portal-venous shunt (TIPSS) is an interventional treatment used for portal hypertension, which is minimally invasive, has low postoperative complications, reduces portal pressure significantly, and has reliable efficacy in controlling bleeding from esophageal varices. With the improvement of technology, TIPSS is effective in treating portal hypertension and can reduce the occurrence of and. At present, only a few hospitals in China carry out this technology.